Tumour necrosis factor α upregulates platelet CD40L in patients with heart failure

Cardiovascular Research

Volumn 78, Issue 3, 2008, Pages 515-522

  Pignatelli, Pasquale ^a   Cangemi, Roberto ^a   Celestini, Andrea ^a   Carnevale, Roberto ^a   Polimeni, Licia ^a   Martini, Alessandra ^a   Ferro, Domenico ^a   Loffredo, Lorenzo ^a   Violi, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

CD40L; Heart failure; Oxidative stress; Platelets; TNF

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ACETYLSALICYLIC ACID; APOCYNIN; ARACHIDONIC ACID; CD40 LIGAND; CYCLOOXYGENASE 1; PHOSPHOLIPASE A2 INHIBITOR; RECEPTOR BLOCKING AGENT; STAUROSPORINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; CELL STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE CLASSIFICATION; FEMALE; HEART FAILURE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY MECHANISM; THROMBOCYTE; UPREGULATION;

ACETOPHENONES; AGED; AGED, 80 AND OVER; ARACHIDONIC ACIDS; ASPIRIN; BLOOD PLATELETS; CASE-CONTROL STUDIES; CD40 LIGAND; CYCLOOXYGENASE 1; DEOXYGUANOSINE; ENZYME INHIBITORS; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NADPH OXIDASE; OXIDATIVE STRESS; PHOSPHOLIPASES A2; PROTEIN KINASE C; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; STAUROSPORINE; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 44449179729     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn040     Document Type: Article

References (29)

1. Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA et al. Acute heart failure syndromes: current state and framework for future research. Circulation 2005;112:3958-3968.
2. Doerries C, Grote K, Hilfiker-Kleiner D, Luchtefeld M, Schaefer A, Holland SM et al. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction. Circ Res 2007;100:894-903.
3. Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 2002;91:988-998.
4. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-241.
5. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996;27:1201-1206.
6. Kelly RA, Smith TW. Cytokines and cardiac contractile function. Circulation 1997;95:778-781.
7. Ueland T, Aukrust P, Yndestad A, Otterdal K, Frøland SS, Dickstein K et al. Soluble CD40 ligand in acute and chronic heart failure. Eur Heart J 2005;26:1101-1107.
8. Sanguigni V, Ferro D, Pignatelli P, Del Ben M, Nadia T, Saliola M et al. CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia. J Am Coll Cardiol 2005;45:35-42.
9. Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003;92:1041-1048.
10. Pignatelli P, De Biase L, Lenti L, Tocci G, Brunelli A, Cangemi R et al. Tumor necrosis factor-alpha as trigger of platelet activation in patients with heart failure. Blood 2005;106:1992-1994.
11. Pignatelli P, Sanguigni V, Lenti L, Ferro D, Finocchi A, Rossi P et al. gp91phox-dependent expression of platelet CD40 ligand. Circulation 2004;110:1326-1329.
12. Gao X, Xu X, Belmadani S, Park Y, Tang Z, Feldman AM et al. TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 2007;27:1269-1275.
13. Ungvari Z, Csiszar A, Edwards JG, Kaminski PM, Wolin MS, Kaley G et al. Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 2003;23:418-424.
14. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 2004;339:1-9.
15. Pignatelli P, Lenti L, Sanguigni V, Frati G, Simeoni I, Gazzaniga PP et al. Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress. Am J Physiol Heart Circ Physiol 2003;284:H41-H48.
16. Stumpf C, Lehner C, Eskafi S, Raaz D, Yilmaz A, Ropers S et al. Enhanced levels of CD154 (CD40 ligand) on platelets in patients with chronic heart failure. Eur J Heart Fail 2003;5:629-637.
17. Chung I, Choudhury A, Lip GY. Platelet activation in acute, decompensated congestive heart failure. Thromb Res 2007;120:709-713.
18. Andre P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO et al. CD40L stabilizes arterial thrombi by a b3 integrin-dependent mechanism. Nat Med 2002;8:247-252.
19. Ledda-Columbano GM, Curto M, Piga R, Zedda AI, Menegazzi M, Sartori C et al. In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway. Oncogene 1998;17:1039-1044.
20. Baj-Krzyworzeka M, Majka M, Pratico D, Ratajczak J, Vilaire G, Kijowski J et al. Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol 2002;30:450-459.
21. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995;92:1479-1486.
22. Danese S, Sans M, Scaldaferri F, Sgambato A, Rutella S, Cittadini A et al. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease. J Immunol 2006;176:2617-2624.
23. Pignatelli P, Sanguigni V, Lenti L, Loffredo L, Carnevale R, Sorge R et al. Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin. J Thromb Haemost 2007;5:1170-1178.
24. De Biase L, Pignatelli P, Lenti L, Tocci G, Piccioni F, Riondino S et al. Enhanced TNF alpha and oxidative stress in patients with heart failure: effect of TNF alpha on platelet O2-production. Thromb Haemost 2003;90:317-325.
25. Vignais PV. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol Life Sci 2002;59:1428-1459.
26. Hackeng CM, Relou IA, Pladet MW, Gorter G, van Rijn HJ, Akkerman JW. Early platelet activation by low density lipoprotein via p38MAP kinase. Thromb Haemost 1999;82:1749-1756.
27. Lip GY, Gibbs CR. Does heart failure confer a hypercoagulable state? Virchow's triad revisited. J Am Coll Cardiol 1999;33:1424-1426.
28. Davis CJ, Gurbel PA, Gattis WA, Fuzaylov SY, Nair GV, O'Connor CM et al. Hemostatic abnormalities in patients with congestive heart failure: diagnostic significance and clinical challenge. Int J Cardiol 2000;75:15-21.
29. Alessandri C, Pignatelli P, Loffredo L, Lenti L, Del Ben M, Carnevale R et al. Alpha-linolenic acid-rich wheat germ oil decreases oxidative stress and CD40 ligand in patients with mild hypercholesterolemia. Arterioscler Thromb Vasc Biol 2006;26:2577-2578.